DE60220024T2 - Pyrimidinnukleosidderivatkristall - Google Patents

Pyrimidinnukleosidderivatkristall Download PDF

Info

Publication number
DE60220024T2
DE60220024T2 DE60220024T DE60220024T DE60220024T2 DE 60220024 T2 DE60220024 T2 DE 60220024T2 DE 60220024 T DE60220024 T DE 60220024T DE 60220024 T DE60220024 T DE 60220024T DE 60220024 T2 DE60220024 T2 DE 60220024T2
Authority
DE
Germany
Prior art keywords
compound
angstroms
formula
crystalline form
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60220024T
Other languages
German (de)
English (en)
Other versions
DE60220024D1 (en
Inventor
Takashi Hiratsuka-shi TAKITA
Keiichi Hiratsuka-shi OHTSUKA
Eiji Hiratsuka-shi NUMAGAMI
Susumu Hiratsuka-shi HARASHIMA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE60220024D1 publication Critical patent/DE60220024D1/de
Publication of DE60220024T2 publication Critical patent/DE60220024T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60220024T 2001-02-09 2002-02-06 Pyrimidinnukleosidderivatkristall Expired - Lifetime DE60220024T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001033128 2001-02-09
JP2001033128 2001-02-09
PCT/JP2002/000986 WO2002064609A1 (en) 2001-02-09 2002-02-06 Crystal of pyrimidine nucleoside derivative

Publications (2)

Publication Number Publication Date
DE60220024D1 DE60220024D1 (en) 2007-06-21
DE60220024T2 true DE60220024T2 (de) 2007-11-22

Family

ID=18896929

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60220024T Expired - Lifetime DE60220024T2 (de) 2001-02-09 2002-02-06 Pyrimidinnukleosidderivatkristall

Country Status (21)

Country Link
EP (1) EP1364959B1 (cg-RX-API-DMAC7.html)
JP (2) JP3748536B2 (cg-RX-API-DMAC7.html)
KR (1) KR100679904B1 (cg-RX-API-DMAC7.html)
CN (1) CN100408591C (cg-RX-API-DMAC7.html)
AT (1) ATE361929T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002230164B2 (cg-RX-API-DMAC7.html)
BR (2) BRPI0207102A8 (cg-RX-API-DMAC7.html)
CA (1) CA2437994C (cg-RX-API-DMAC7.html)
CY (1) CY1106685T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ303241B6 (cg-RX-API-DMAC7.html)
DE (1) DE60220024T2 (cg-RX-API-DMAC7.html)
DK (1) DK1364959T3 (cg-RX-API-DMAC7.html)
ES (1) ES2286237T3 (cg-RX-API-DMAC7.html)
HU (1) HU229294B1 (cg-RX-API-DMAC7.html)
IL (2) IL157216A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03007123A (cg-RX-API-DMAC7.html)
NZ (1) NZ527393A (cg-RX-API-DMAC7.html)
PT (1) PT1364959E (cg-RX-API-DMAC7.html)
RU (1) RU2256666C2 (cg-RX-API-DMAC7.html)
WO (1) WO2002064609A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200306121B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2081419B1 (en) 1999-09-02 2013-08-07 Ibiden Co., Ltd. Printed circuit board and method of manufacturing printed circuit board
CN101232776B (zh) 1999-09-02 2011-04-20 揖斐电株式会社 印刷布线板
GB0526419D0 (en) 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
GB0625283D0 (en) 2006-12-19 2007-01-24 Cyclacel Ltd Combination
JP5066737B2 (ja) * 2007-04-06 2012-11-07 大鵬薬品工業株式会社 シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤
US8124593B2 (en) 2007-11-05 2012-02-28 Cyclacel Limited Methods of treatment using sapacitabine
GB0808357D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
PL2307002T3 (pl) 2008-06-09 2013-05-31 Cyclacel Ltd Kombinacje sapacytabiny lub cndac z inhibitorami metylotransferazy dna, takimi jak decytabina i prokaina
PL2696878T3 (pl) 2011-04-14 2020-01-31 Cyclacel Limited Schemat dawkowania dla sapacytabiny i decytabiny w kombinacji do leczenia ostrej białaczki szpikowej
ES2880109T3 (es) 2012-03-15 2021-11-23 Celgene Car Llc Formas sólidas de un inhibidor de la cinasa del receptor del factor de crecimiento epidérmico
ES2963057T3 (es) * 2015-03-09 2024-03-25 Grace W R & Co Forma cristalina de ribósido de nicotinamida
EP3727400A4 (en) 2017-12-22 2021-10-20 Elysium Health, Inc. CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2559917B2 (ja) * 1990-06-15 1996-12-04 三共株式会社 ピリミジンヌクレオシド誘導体
FI105556B (fi) * 1991-09-30 2000-09-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta

Also Published As

Publication number Publication date
HUP0303159A3 (en) 2007-06-28
AU2002230164B2 (en) 2005-04-07
HUP0303159A2 (hu) 2003-12-29
BRPI0207102A8 (pt) 2018-02-27
KR100679904B1 (ko) 2007-02-07
CA2437994C (en) 2011-05-17
WO2002064609A1 (en) 2002-08-22
CZ20032111A3 (cs) 2003-12-17
CN1501939A (zh) 2004-06-02
KR20030081424A (ko) 2003-10-17
IL157216A0 (en) 2004-02-19
ES2286237T3 (es) 2007-12-01
CY1106685T1 (el) 2012-05-23
HU229294B1 (en) 2013-10-28
EP1364959B1 (en) 2007-05-09
ZA200306121B (en) 2005-01-26
CA2437994A1 (en) 2002-08-22
DK1364959T3 (da) 2007-06-04
EP1364959A1 (en) 2003-11-26
NZ527393A (en) 2004-07-30
PT1364959E (pt) 2007-07-23
RU2256666C2 (ru) 2005-07-20
ATE361929T1 (de) 2007-06-15
BR0207102A (pt) 2004-01-27
JP4356998B2 (ja) 2009-11-04
JP2006008699A (ja) 2006-01-12
EP1364959A4 (en) 2004-03-24
CN100408591C (zh) 2008-08-06
IL157216A (en) 2008-03-20
MXPA03007123A (es) 2003-11-18
JP2002308895A (ja) 2002-10-23
JP3748536B2 (ja) 2006-02-22
RU2003124648A (ru) 2005-02-27
DE60220024D1 (en) 2007-06-21
CZ303241B6 (cs) 2012-06-13

Similar Documents

Publication Publication Date Title
DE3888913T2 (de) Kristallines beta-Lactam-Hydrat.
EA014164B1 (ru) Новая кристаллическая форма производного пиридазино[4,5-в]индола
EP3160951B1 (en) Crystalline forms of ferric maltol
EP1364959B1 (en) Crystal of pyrimidine nucleoside derivative
DE60107074T2 (de) Kristallin form ii von cabergolin
US6908906B2 (en) Crystalline forms of pyrimidine nucleoside derivative
DE602004004453T2 (de) Stabile pharmazeutische zusammensetzungen mit desloratadin
DE69510999T2 (de) Terazosinmonohydrochlorid und Verfahren und Zwischenprodukte für seine Herstellung
DE60106421T2 (de) Hydrate und kristalle einer neuraminsäureverbindung
DE3443065C2 (cg-RX-API-DMAC7.html)
DE69621253T2 (de) Neue kristalline form von morphin-6-glucucronid
DE69015834T2 (de) 6-Chlor-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzodiazepin-carbamate als Pro-Arzneimittel.
DE60019461T2 (de) Neue polymorphe formen von olanzapin
DE69706562T2 (de) N-(4-acetyl-1-piperazinyl)-4-fluorobenzamidhydrat
DE69418953T2 (de) Kristalle einer antimikrobiellen Verbindung
EP0496274A1 (de) Tricyclisches Pyridonderivat
DE602005005843T2 (de) 4 ä(2,4-dichloro-5-methoxyphenyl)aminoü-6-alkoxy-7-ethynyl-3-chinolincarbonitrile zur behandlung von ischämie
DE60104822T2 (de) Pseudopolymorph von (-)-cis-2-(2-chlorphenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-on hydrochlorid
DE68907893T2 (de) Neue 1,3,4,-thiadiazolderivate und antigeschwulstmittel, die diese enthalten.
US20040122034A1 (en) Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-1yl)acetamide
DE19541921A1 (de) Neue Kristallform von Morphin-6-glucuronid
EP4684834A1 (de) Kristallformen onkologisch wirksamer imipridone und verfahren zu deren herstellung
DE69611407T2 (de) Alternative Kristallform von Tazofelon ((+,-)-5-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methyl)-4-thiazolidinon)
HK1233619B (en) Crystalline forms of ferric maltol
HK1233619A1 (en) Crystalline forms of ferric maltol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition